Zobrazeno 1 - 10
of 30
pro vyhledávání: '"S. Yasar Bilge"'
Autor:
J. Culerrier, Y. Nguyen, O. Karadag, S. Yasar Bilge, A. Kronbichler, D. Jayne, A. Régent, V. Teixeira, S. Marchand-Adam, P. Duffau, S. Oro, C. Droumaguet, B. Andre, L. Luca, S. Lechtman, A. Aouba, C. Lebas, A. Servettaz, X. Puéchal, B. Terrier
Publikováno v:
La Revue de Médecine Interne. 43:A377
Autor:
E. Durak Ediboglu, U. Kalyoncu, D. Solmaz, T. Kaşifoğlu, E. Tekgoz, C. Bes, A. Erden, B. Yağiz, N. A. Kanitez, A. İ. Ertenli, B. N. Coşkun, R. Mercan, S. Kiraz, V. Yazisiz, O. Küçükşahin, A. Ateş, R. Yilmaz, Y. Pehlivan, H. Emmungil, N. S. Yasar Bilge, G. Kimyon, E. D. Ersözlü, E. Dalkiliç, S. S. Koca, S. Akar
Publikováno v:
Annals of the Rheumatic Diseases. 81:812.2-813
BackgroundAxial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease affecting sacroiliac joints, spine and peripheral joints. In addition to spinal and peripheral manifestations, root joints (hip or sholder) involvement may also dev
Publikováno v:
Annals of the Rheumatic Diseases. 81:1752.3-1753
BackgroundUveitis is still an important cause of morbidity leading to vision loss in Behcet’s syndrome (BS).ObjectivesOur aim in this study was to retrospectively evaluate characteristics of uveitis, long term complications, and its association wit
Autor:
R. Mercan, M. E. Tezcan, B. Yağiz, A. Ateş, O. Küçükşahin, N. S. Yasar Bilge, N. A. Kanitez, E. Gönüllü, S. Yilmaz, D. Ersözlü, D. Solmaz, T. Kaşifoğlu, B. N. Coşkun, S. S. Koca, E. Bilgin, V. Yazisiz, E. Dalkiliç, R. Yilmaz, G. Kimyon, G. Ayan, A. Erden, C. Bes, H. Emmungil, Y. Pehlivan, A. İ. Ertenli, S. Kiraz, U. Kalyoncu
Publikováno v:
Annals of the Rheumatic Diseases. 81:1509.2-1510
BackgroundBiological therapies are the main treatment options for patients with active spondyloarthropathy (SpA) who do not respond to nonsteroidal anti-inflammatory drugs or conventional synthetic disease-modifying drugs. Kidney diseases are not a c
Publikováno v:
Annals of the Rheumatic Diseases. 81:1752.1-1752
BackgroundCardiac involvement is an uncommonly seen but might be a fatal clinical manifestation of Behcet’s syndrome (BS), if not recognized early and treated aggressively.ObjectivesOur aim was to retrospectively evaluate the characteristics of car
Publikováno v:
Annals of the Rheumatic Diseases. 81:1010.2-1010
BackgroundPulmonary involvement (PI) other than pulmonary artery aneurysm (PAA) in Behcet’s syndrome (BS) is still an area of investigation.ObjectivesHerein, we aimed to retrospectively evaluate all types of pulmonary involvement associated with Be
Autor:
Burcu Yağız, Sinan Koca, Emel Gönüllü, Omer Karadag, Cemal Bes, Emre Tekgöz, G. Kabadayi, T. Kasifoglu, Belkıs Nihan Coşkun, Ali İhsan Ertenli, M. Cinar, Gezmiş Kimyon, E. Durak Ediboglu, Rıdvan Mercan, Orhan Küçükşahin, Servet Akar, N. S. Yasar Bilge, Duygu Ersözlü, Aşkın Ateş, Nilüfer Alpay Kanıtez, Yavuz Pehlivan, Dilek Solmaz, Seda Colak, Umut Kalyoncu, Sedat Kiraz, Veli Yazisiz, Hakan Emmungil, Pamir Atagündüz
Publikováno v:
Annals of the Rheumatic Diseases. 80:731.1-731
Background:Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease mainly affecting sacroiliac joints and spine. Peripheral arthritis, dactylitis and enthesitis may also occur. Extra musculoskeletal manifestations (EMMs; uveitis [
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Onay Gercik, Gezmiş Kimyon, Cemal Bes, Rıdvan Mercan, Umut Kalyoncu, Burcu Yağız, Sedat Kiraz, Yavuz Pehlivan, Servet Akar, M. Cinar, Timuçin Kaşifoğlu, Ediz Dalkilic, Belkis Nihan Seniz, D. Ersözlü, Omer Karadag, Hakan Emmungil, N. S. Yasar Bilge, Levent Kilic, Ali İhsan Ertenli
Publikováno v:
Annals of the Rheumatic Diseases. 79:1620.2-1620
Background:Biosimilar infliximab (bio-INF) was approved for all indications of the reference product in several countries. It has been marketed since 2014 in Turkey and used in the same indications with its bio-originator.Objectives:Herein, we aimed
Autor:
Andrés Moya, Ener Cagri Dinleyici, Timuçin Kaşifoğlu, Uğur Bilge, Nilgun Kasifoglu, V. Perez Brocal, N. S. Yasar Bilge
Publikováno v:
Annals of the Rheumatic Diseases. 79:1809.2-1809
Background:Although Familial Mediterranean Fever (FMF) is a monogenic disease, microbiota composition may play role in the pathogenesis or phenotypic expression.Objectives:We aim to evaluate the intestinal microbiota composition in patients with FMF